FindTrial
Sign In

Evidence-Based Self-management In Multiple Sclerosis (EBSIMS). A multi-centre, randomised controlled trial to investigate the effects of a structured educational programme on relapse management in Multiple Sclerosis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN73885145
Enrollment
Unknown
Registered
2004-08-09
Start date
2003-04-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsing-remitting Multiple Sclerosis (MS) Nervous System Diseases Multiple sclerosis

Interventions

Intervention group: Participants in the intervention group are provided with a brochure, critically appraising the evidence on relapses and relapse management, considering aspects of evidence-based me

Sponsors

University of Hamburg (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with relapsing-remitting Multiple Sclerosis (MS), with at least 2 relapses in the last 24 months or at least one relapse in the last 12 months.

Exclusion criteria

Exclusion criteria: Patients with severe cognitive deficits or pregnancy

Design outcomes

Primary

MeasureTime frame
Percentage of relapses without steroid-treatment or with oral steroid-treatment within 2 years of follow-up.—

Secondary

MeasureTime frame
1. Time to initiation of treatment 2. Overall costs 3. Characteristics of steroid-treatments 4. Changes in autonomy preferences 5. Protection motivation 6. Quality of life 7. Relapse severity 8. Adverse treatment effects 9. Other clinical variables—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026